ResearcherEdinburgh Royal InfirmaryActive in the last 2 years

James E. Lucocq

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6979-7818; OpenAlex author ID A5055348142. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272 ↗
Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research. Co-author DOI 10.1093/bjs/znae238 ↗
ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary … Co-author DOI 10.1245/s10434-024-15784-x ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sanjay Pandanaboyana · 2 shared papers, 2024 · strength 0.82
- Paper Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research. DOI 10.1093/bjs/znae238 ↗
- Paper ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarci… DOI 10.1245/s10434-024-15784-x ↗
Kjetil Søreide · 1 shared paper, 2024 · strength 0.36
- Paper ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarci… DOI 10.1245/s10434-024-15784-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.